These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 16674978)

  • 1. Pseudobulbar affect in multiple sclerosis: toward the development of innovative therapeutic strategies.
    Miller A
    J Neurol Sci; 2006 Jun; 245(1-2):153-9. PubMed ID: 16674978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic use of dextromethorphan: key learnings from treatment of pseudobulbar affect.
    Miller A; Panitch H
    J Neurol Sci; 2007 Aug; 259(1-2):67-73. PubMed ID: 17433820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dextromethorphan/quinidine for the treatment of pseudobulbar affect.
    Patatanian E; Casselman J
    Consult Pharm; 2014 Apr; 29(4):264-9. PubMed ID: 24704895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis.
    Panitch HS; Thisted RA; Smith RA; Wynn DR; Wymer JP; Achiron A; Vollmer TL; Mandler RN; Dietrich DW; Fletcher M; Pope LE; Berg JE; Miller A;
    Ann Neurol; 2006 May; 59(5):780-7. PubMed ID: 16634036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involuntary emotional expression disorder in Alzheimer's disease - psychopharmacotherapy aspects.
    Mimica N; Drmić S; Presecki P
    Psychiatr Danub; 2009 Sep; 21(3):425-8. PubMed ID: 19794369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dextromethorphan/quinidine on auditory event-related potentials in multiple sclerosis patients with pseudobulbar affect.
    Haiman G; Pratt H; Miller A
    J Clin Psychopharmacol; 2009 Oct; 29(5):444-52. PubMed ID: 19745644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dextromethorphan/quinidine: in pseudobulbar affect.
    Garnock-Jones KP
    CNS Drugs; 2011 May; 25(5):435-45. PubMed ID: 21476614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dextromethorphan/quinidine: a review of its use in adults with pseudobulbar affect.
    Yang LP; Deeks ED
    Drugs; 2015 Jan; 75(1):83-90. PubMed ID: 25420446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudobulbar affect: the spectrum of clinical presentations, etiologies and treatments.
    Miller A; Pratt H; Schiffer RB
    Expert Rev Neurother; 2011 Jul; 11(7):1077-88. PubMed ID: 21539437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A real reason for patients with pseudobulbar affect to smile.
    Rosen HJ; Cummings J
    Ann Neurol; 2007 Feb; 61(2):92-6. PubMed ID: 17212357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open-label multicenter study to assess the safety of dextromethorphan/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditions.
    Pattee GL; Wymer JP; Lomen-Hoerth C; Appel SH; Formella AE; Pope LE
    Curr Med Res Opin; 2014 Nov; 30(11):2255-65. PubMed ID: 25062507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury.
    Hammond FM; Alexander DN; Cutler AJ; D'Amico S; Doody RS; Sauve W; Zorowitz RD; Davis CS; Shin P; Ledon F; Yonan C; Formella AE; Siffert J
    BMC Neurol; 2016 Jun; 16():89. PubMed ID: 27276999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dextromethorphan/quinidine sulfate for pseudobulbar affect.
    Rosen H
    Drugs Today (Barc); 2008 Sep; 44(9):661-8. PubMed ID: 19137121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain responses to verbal stimuli among multiple sclerosis patients with pseudobulbar affect.
    Haiman G; Pratt H; Miller A
    J Neurol Sci; 2008 Aug; 271(1-2):137-47. PubMed ID: 18504049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of pseudobulbar affect (PBA) in a patient with a history of traumatic brain injury, partial brain resection, and brainstem stroke: a case report.
    Young FG; Nguyen D
    J Med Case Rep; 2020 Dec; 14(1):235. PubMed ID: 33272325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudobulbar affect: burden of illness in the USA.
    Colamonico J; Formella A; Bradley W
    Adv Ther; 2012 Sep; 29(9):775-98. PubMed ID: 22941524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dextromethorphan-quinidine-responsive pseudobulbar affect (PBA): psychopharmacological model for wide-ranging disorders of emotional expression?
    Stahl SM
    CNS Spectr; 2016 Dec; 21(6):419-423. PubMed ID: 27855728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current concepts in the pharmacotherapy of pseudobulbar affect.
    Pioro EP
    Drugs; 2011 Jun; 71(9):1193-207. PubMed ID: 21711063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudobulbar affect: an under-recognized and under-treated neurological disorder.
    Work SS; Colamonico JA; Bradley WG; Kaye RE
    Adv Ther; 2011 Jul; 28(7):586-601. PubMed ID: 21660634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involuntary emotional expression disorder - new/old disease in psychiatry and neurology.
    Presecki P; Mimica N
    Psychiatr Danub; 2007 Sep; 19(3):184-8. PubMed ID: 17914317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.